SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eye Laser Industry - VISX and Summit BEAM Info
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Parkinson who wrote (6)8/9/1996 9:56:00 AM
From: Daryl Gresham   of 178
 
I started out with Summit stock because they had FDA approval before VISX. I dumped Summit at a considerable loss after VISX got FDA approval and then turned around and bought VISX. I sold VISX at a small profit just before the big correction and then bought more after it went down. I wouldn't touch Summit at all after reading the stories about their back stabbing and devious activities. That leaves VISX as the only way to go. I've had RK surgery for myopia and astygmatism and it's great not having to wear glasses after 33 years of having to wear them all the time! It's well worth the cost. This market is still in it's early stages and I'm sure will grow tremendously with VISX leading the way. FDA approval for full use of the VISX laser for high myopia and astygmatism has got to come fairly soon since it has been so successful in Europe and Canada.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News